The Nanobiotechnology group
The Nanobiotechnology group is focusing on interdisciplinary research with a focus to combine nanotechnology and microfluidics with various biotechnology and medical applications.
Microfluidics hold great promise for miniaturizing and improving many biological methods. Microfluidic devices combine low reagent volumes, reduced analysis times and increased sensitivity with potentially low-cost fabrication. A multitude of microfluidic devices for chemical and biological separation, detection and processing have been developed. The Nanobiotechnology group was initiated in 2005 and consists today of approximately 30 people with a wide variety of backgrounds such as electrical engineering, medicine, biotechnology, chemistry and physics creating a very dynamic and interdisciplinary environment. We are currently focusing on three different areas: droplet microfluidics, clinical microfluidics and point of care systems.
Group leader: Prof. Helene Andersson Svahn,